UPDATED May 09, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
CTSH | US$66.80 | 0.8% | 8.0% | US$33.7b | US$77.38 | PE15.9x | E9.0% | 1.8% | ||
FICO | US$1,286.78 | 10.4% | 71.7% | US$30.9b | US$1,316.77 | PE66.1x | E17.2% | 0% | ||
HUBS | US$587.15 | -0.6% | 27.2% | US$30.0b | US$678.91 | PS13.1x | E53.7% | n/a | ||
ANSS | US$327.25 | 4.0% | 10.6% | US$28.5b | US$348.94 | PE65.7x | E17.0% | n/a | ||
SPLK | US$156.90 | 0.3% | 74.8% | US$26.4b | US$156.89 | PE100.3x | E26.4% | n/a | ||
MDB | US$354.69 | -2.3% | 34.3% | US$25.7b | US$446.02 | PS15.3x | E25.1% | n/a | ||
ZS | US$171.96 | -2.5% | 49.0% | US$25.6b | US$258.54 | PS13.6x | E41.6% | n/a | ||
NET | US$73.34 | -17.6% | 46.6% | US$24.6b | US$91.16 | PS18x | E24.1% | n/a | ||
APP | US$84.69 | 16.9% | 285.0% | US$24.4b | US$79.74 | PE47x | E30.7% | n/a | ||
GIB.A | CA$139.32 | -0.3% | 0.7% | CA$32.4b | CA$156.47 | PE19.3x | E7.4% | n/a | ||
MSTR | US$1,263.64 | 11.9% | 339.7% | US$21.9b | US$1,450.40 | PS45.8x | E41.9% | n/a | ||
PTC | US$180.00 | 5.5% | 39.0% | US$21.4b | US$203.06 | PE74.9x | E22.6% | n/a | ||
IOT | US$39.75 | 8.0% | 107.9% | US$21.1b | US$41.40 | PS23.3x | E13.2% | n/a | ||
WTC | AU$96.72 | 4.8% | 36.3% | AU$31.7b | AU$88.99 | PE144.5x | E27.2% | 0.2% | ||
TYL | US$481.84 | 3.7% | 24.0% | US$20.4b | US$500.39 | PE108.1x | E18.3% | n/a | ||
ZM | US$61.13 | -2.7% | -5.2% | US$19.0b | US$78.49 | PE29.8x | E4.1% | n/a | ||
GDDY | US$131.93 | 6.1% | 87.3% | US$18.5b | US$140.44 | PE10.8x | E-9.6% | n/a | ||
CHKP | US$152.38 | 1.9% | 26.0% | US$17.5b | US$171.76 | PE20.5x | E4.0% | n/a | ||
BSY | US$55.01 | 6.3% | 21.6% | US$17.2b | US$60.07 | PE49.6x | E6.9% | 0.4% | ||
VRSN | US$169.79 | 0.9% | -23.0% | US$16.8b | US$205.00 | PE20.3x | E3.9% | n/a | ||
OKTA | US$98.12 | 2.8% | 24.4% | US$16.3b | US$113.22 | PS7.3x | E47.0% | n/a | ||
NTNX | US$67.58 | 8.7% | 179.3% | US$16.2b | US$68.11 | PS8.2x | E82.7% | n/a | ||
AKAM | US$102.46 | 2.7% | 19.3% | US$15.6b | US$125.95 | PE28.7x | E13.7% | n/a | ||
SGE | UK£12.06 | 3.9% | 47.6% | UK£12.0b | UK£12.20 | PE57.1x | E17.4% | 1.6% |